Laurion Capital Management’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-116,600
| Closed | -$1.05M | – | 710 |
|
|
2020
Q3 | $1.05M | Buy |
+116,600
| New | +$1.05M | 0.01% | 246 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 711 |
|
|
2019
Q4 | – | Sell |
-269,100
| Closed | -$1.85M | – | 812 |
|
|
2019
Q3 | $1.85M | Buy |
269,100
+162,300
| +152% | +$1.12M | 0.01% | 176 |
|
|
2019
Q2 | $986K | Buy |
+106,800
| New | +$986K | 0.01% | 279 |
|
|
2019
Q1 | – | Sell |
-12,818
| Closed | -$198K | – | 876 |
|
|
2018
Q4 | $198K | Buy |
12,818
+10,700
| +505% | +$165K | ﹤0.01% | 598 |
|
|
2018
Q3 | $46K | Sell |
2,118
-5,050
| -70% | -$110K | ﹤0.01% | 718 |
|
|
2018
Q2 | $174K | Sell |
7,168
-8,050
| -53% | -$195K | ﹤0.01% | 957 |
|
|
2018
Q1 | $260K | Sell |
15,218
-167,000
| -92% | -$2.85M | ﹤0.01% | 889 |
|
|
2017
Q4 | $3.45M | Buy |
182,218
+19,129
| +12% | +$362K | 0.02% | 300 |
|
|
2017
Q3 | $2.87M | Buy |
+163,089
| New | +$2.87M | 0.01% | 298 |
|
|
2017
Q2 | – | Sell |
-107,579
| Closed | -$3.45M | – | 1336 |
|
|
2017
Q1 | $3.45M | Buy |
107,579
+48,474
| +82% | +$1.56M | 0.03% | 158 |
|
|
2016
Q4 | $2.14M | Sell |
59,105
-828,164
| -93% | -$30M | 0.02% | 212 |
|
|
2016
Q3 | $40.8M | Buy |
887,269
+460,559
| +108% | +$21.2M | 0.38% | 12 |
|
|
2016
Q2 | $21.4M | Sell |
426,710
-40,883
| -9% | -$2.05M | 0.34% | 11 |
|
|
2016
Q1 | $25M | Buy |
467,593
+160,952
| +52% | +$8.61M | 0.39% | 7 |
|
|
2015
Q4 | $20.1M | Buy |
306,641
+262,941
| +602% | +$17.3M | 0.19% | 16 |
|
|
2015
Q3 | $2.47M | Buy |
+43,700
| New | +$2.47M | 0.03% | 74 |
|
|
2014
Q3 | – | Hold |
0
| – | – | – | 269 |
|
|
2014
Q2 | – | Hold |
0
| – | – | – | 213 |
|